Showing 1 - 11 results of 11 for search 'Alessandro Cozzi-Lepri', query time: 0.03s
Refine Results
-
1
Probability of Starting Two-Drug Regimen (2DR) vs. Three-Drug Regimen (3DR) in ART-Naïve and ART-Experienced Person with HIV (PWH) Across the First Wave of COVID-19 Pandemic by Alessandra Vergori, Nicola Gianotti, Alessandro Tavelli, Camilla Tincati, Andrea Giacomelli, Elena Matteini, Giuseppe Lapadula, Lucia Taramasso, Loredana Sarmati, Antonella D’Arminio Monforte, Andrea Antinori, Alessandro Cozzi-Lepri, on behalf of the ICONA Foundation Study
Published 2024-11-01Get full text
Article -
2
Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy. by Birgit Grund, Jason V Baker, Steven G Deeks, Julian Wolfson, Deborah Wentworth, Alessandro Cozzi-Lepri, Calvin J Cohen, Andrew Phillips, Jens D Lundgren, James D Neaton, INSIGHT SMART/ESPRIT/SILCAAT Study Group
Published 2016-01-01Get full text
Article -
3
Assessing the utilization of HIV genotype resistance testing: Insight from Italian Infectious Diseases Units by Andrea De Vito, Antonia Bezenchek, Rossana Scutari, Luna Colagrossi, Giacomo Valenti, Maria Concetta Bellocchi, Luca Pipitò, Sergio Ferrara, Sergio Malandrin, Monica Tallarita, Alessandro Cozzi-Lepri, Francesca Ceccherini-Silberstein, Sergio Lo Caputo, Stefano Rusconi
Published 2025-05-01Get full text
Article -
4
Can linear regression modeling help clinicians in the interpretation of genotypic resistance data? An application to derive a lopinavir-score. by Alessandro Cozzi-Lepri, Mattia C F Prosperi, Jesper Kjær, David Dunn, Roger Paredes, Caroline A Sabin, Jens D Lundgren, Andrew N Phillips, Deenan Pillay, EuroSIDA Study, United Kingdom CHIC/United Kingdom HDRD Study
Published 2011-01-01Get full text
Article -
5
Timing of antiretroviral therapy initiation after a first AIDS-defining event: temporal changes in clinical attitudes in the ICONA cohort. by Antonella Cingolani, Alessandro Cozzi-Lepri, Adriana Ammassari, Cristina Mussini, Maria Alessandra Ursitti, Pietro Caramello, Gioacchino Angarano, Paolo Bonfanti, Andrea De Luca, Maria Stella Mura, Enrico Girardi, Andrea Antinori, Antonela D'Arminio Monforte, Icona Foundation Study group
Published 2014-01-01Get full text
Article -
6
CT changes in a randomized trial comparing early therapies in an outpatient population at high risk of severe COVID19 disease by Ilaria Mastrorosa, Alessandro Cozzi-Lepri, Giulia Matusali, Francesca Colavita, Simone Lanini, Martina Rueca, Alessandra Oliva, Giulia Berno, Alessandra Vergori, Silvia Rosati, Jessica Paulicelli, Enrico Girardi, Emanuele Nicastri, Fabrizio Maggi, Andrea Antinori, Valentina Mazzotta, the MONET Clinical Trial Group
Published 2025-08-01Get full text
Article -
7
Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced disease: A trial emulation by Roberta Gagliardini, Andrea Giacomelli, Cristina Mussini, Stephen R. Cole, Jessie K. Edwards, Carmela Pinnetti, Alessandro Raimondi, Spinello Antinori, Silvia Nozza, Valentina Mazzotta, Giulia Carla Marchetti, Sergio Lo Caputo, Alessandro Tavelli, Antonella d'Arminio Monforte, Andrea Antinori, Alessandro Cozzi-Lepri
Published 2025-06-01Get full text
Article -
8
Outcomes of influenza A(H1N1)pdm09 virus infection: results from two international cohort studies. by Ruth Lynfield, Richard Davey, Dominic E Dwyer, Marcelo H Losso, Deborah Wentworth, Alessandro Cozzi-Lepri, Kathy Herman-Lamin, Grazyna Cholewinska, Daniel David, Stefan Kuetter, Zelalem Ternesgen, Timothy M Uyeki, H Clifford Lane, Jens Lundgren, James D Neaton, INSIGHT Influenza Study Group
Published 2014-01-01Get full text
Article -
9
The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies. by Richard T Davey, Ruth Lynfield, Dominic E Dwyer, Marcello H Losso, Alessandro Cozzi-Lepri, Deborah Wentworth, H Clifford Lane, Robin Dewar, Adam Rupert, Julia A Metcalf, Sarah L Pett, Timothy M Uyeki, Jose Maria Bruguera, Brian Angus, Nathan Cummins, Jens Lundgren, James D Neaton, INSIGHT FLU 002 & 003 Study Groups
Published 2013-01-01Get full text
Article -
10
The Omicron Variant Is Associated with a Reduced Risk of the Post COVID-19 Condition and Its Main Phenotypes Compared to the Wild-Type Virus: Results from the EuCARE-POSTCOVID-19 S... by Francesca Bai, Andrea Santoro, Pontus Hedberg, Alessandro Tavelli, Sara De Benedittis, Júlia Fonseca de Morais Caporali, Carolina Coimbra Marinho, Arnaldo Santos Leite, Maria Mercedes Santoro, Francesca Ceccherini Silberstein, Marco Iannetta, Dovilé Juozapaité, Edita Strumiliene, André Almeida, Cristina Toscano, Jesús Arturo Ruiz-Quiñones, Chiara Mommo, Iuri Fanti, Francesca Incardona, Alessandro Cozzi-Lepri, Giulia Marchetti
Published 2024-09-01Get full text
Article -
11
Common genetic variation and the control of HIV-1 in humans. by Jacques Fellay, Dongliang Ge, Kevin V Shianna, Sara Colombo, Bruno Ledergerber, Elizabeth T Cirulli, Thomas J Urban, Kunlin Zhang, Curtis E Gumbs, Jason P Smith, Antonella Castagna, Alessandro Cozzi-Lepri, Andrea De Luca, Philippa Easterbrook, Huldrych F Günthard, Simon Mallal, Cristina Mussini, Judith Dalmau, Javier Martinez-Picado, José M Miro, Niels Obel, Steven M Wolinsky, Jeremy J Martinson, Roger Detels, Joseph B Margolick, Lisa P Jacobson, Patrick Descombes, Stylianos E Antonarakis, Jacques S Beckmann, Stephen J O'Brien, Norman L Letvin, Andrew J McMichael, Barton F Haynes, Mary Carrington, Sheng Feng, Amalio Telenti, David B Goldstein, NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI)
Published 2009-12-01Get full text
Article